BNB
618.36
19-November-24 13:37:25
realtime
Instruments
-0.65
-0.11%
Today's range
611.71 - 621.32
ISIN
FXBNBUSD
-
Triumph Group (NYSE:TGI) Price Target Raised to $21.00
19 Nov 2024 12:21:09 By Buzz FX
-
Apple (NASDAQ:AAPL) Price Target Lowered to $202.00 at Moffett Nathanson
19 Nov 2024 12:21:09 By Buzz FX
-
Alnylam Pharmaceuticals' (ALNY) Outperform Rating Reiterated at William Blair
19 Nov 2024 12:21:09 By Buzz FX
-
19 Nov 2024 12:16:20 By Buzz FX
-
Intertek Group (LON:ITRK) Raised to "Hold" at Shore Capital
19 Nov 2024 12:16:08 By Buzz FX
-
Barclays Issues Pessimistic Forecast for Alibaba Group (NYSE:BABA) Stock Price
19 Nov 2024 12:16:08 By Buzz FX
-
Kemper (NYSE:KMPR) Stock Price Expected to Rise, TD Cowen Analyst Says
19 Nov 2024 12:16:08 By Buzz FX
-
Bread Financial (NYSE:BFH) Price Target Raised to $58.00 at The Goldman Sachs Group
19 Nov 2024 12:16:08 By Buzz FX
-
Citigroup Forecasts Strong Price Appreciation for Hewlett Packard Enterprise (NYSE:HPE) Stock
19 Nov 2024 12:16:08 By Buzz FX
-
BMO Capital Markets Issues Pessimistic Forecast for Ashland (NYSE:ASH) Stock Price
19 Nov 2024 12:16:08 By Buzz FX
-
agilon health's (AGL) "Outperform" Rating Reaffirmed at Royal Bank of Canada
19 Nov 2024 12:16:08 By Buzz FX
-
Neurogene (NASDAQ:NGNE) Earns Outperform Rating from William Blair
19 Nov 2024 12:16:08 By Buzz FX
-
Berenberg Bank Reiterates "Hold" Rating for BHP Group (LON:BHP)
19 Nov 2024 12:16:08 By Buzz FX
-
Datadog (NASDAQ:DDOG) Given Buy Rating at TD Cowen
19 Nov 2024 12:16:08 By Buzz FX
-
Larimar Therapeutics (NASDAQ:LRMR) Given "Outperform" Rating at William Blair
19 Nov 2024 12:16:08 By Buzz FX
-
Shore Capital Reiterates "Buy" Rating for GB Group (LON:GBG)
19 Nov 2024 12:16:08 By Buzz FX
-
Barclays Has Lowered Expectations for Celanese (NYSE:CE) Stock Price
19 Nov 2024 12:16:08 By Buzz FX
-
Protagonist Therapeutics (NASDAQ:PTGX) Given Outperform Rating at Wedbush
19 Nov 2024 12:16:08 By Buzz FX
-
TD Cowen Forecasts Strong Price Appreciation for Trip.com Group (NASDAQ:TCOM) Stock
19 Nov 2024 12:16:08 By Buzz FX
-
Silence Therapeutics (NASDAQ:SLN) Receives "Outperform" Rating from William Blair
19 Nov 2024 12:16:08 By Buzz FX